This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AKAM ANF BID MNKD WDC


Autodesk (ADSK) was upgraded to buy at Canaccord Genuity. $60 12-month price target. The company is leveraged to tailwinds in commercial construction, Canaccord said.

Akamai (AKAM - Get Report) was upgraded to outperform from sector perform at Pacific Crest. $65 12-month price target. Media traffic growth continues to accelerate, Pacific Crest said.

Abercrombie & Fitch (ANF) was downgraded to hold at TheStreet Ratings.

Must Read: Analysts' Actions: AAPL FUEL OXY TWTR VSI

Sotheby's (BID) was downgraded to hold at TheStreet Ratings.

IMS Health (IMS) was initiated with an equal weight rating at Barclays. $27 12-month price target. Consolidation in the pharma client could constrain multiples, Barclays said.

Lear (LEA) was upgraded at to buy from hold at Deutsche Bank. $100 12-month price target. The seating business may be at an inflection point, said Deutsche Bank.

Legg Mason (LM) was upgraded to buy at Citigroup. The company should see an inflection point in asset flows, Citi said.

Mannkind (MNKD) was upgraded to neutral from underweight at Piper Jaffray. $6.50 12-month price target. The company had a positive FDA panel and the valuation is more attractive ahead of the July 15 PDUFA, said Piper Jaffray.

MWI Veterinary Supply (MWIV) was initiated with a buy rating at UBS. $168 12-month price target. This was a valuation call, with the recent acquisition being more accretive than initially realized, UBS said.

Nielsen Holdings (NLSN) was initiated with an overweight rating at Barclays. $55 12-month price target. The company is driven by growth in the global middle class, modernization of global trade and media fragmentation, said Barclays.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AKAM $39.57 -3.44%
WDC $40.18 -4.13%
AAPL $94.99 -0.02%
FB $99.54 -0.21%
GOOG $678.11 -0.68%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs